Key Metrics
Recent changes
- Sep 24, 2026Sep 24, 2026Bamboo Insurance Pulls Its IPO Just Before Pricing Pulse story
- Sep 21, 2026Sep 21, 2026Bamboo Insurance's IPO Won't Give The Company A Dollar Pulse story
- Sep 14, 2026Sep 14, 2026IPO Up to $700M at Up to $3.24B Bloomberg
- Sep 14, 2026Sep 14, 2026First reported revenue: $173M (H1 2026) Bloomberg
- Dec 8, 2025Dec 8, 2025First reported valuation: $1.75BRumored Insurance Journal / Reuters
Funding History
1 event · sources dated per row| Date | Event | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| Sep 14, 2026 | ipo | Up to $700M | Up to $3.24B | CVC Capital PartnersWhite Mountains Insurance Group | Bloomberg |
Latest Pulse
- Sep 30, 2026Oura's IPO Delay Isn't A One-Company StoryOura's IPO postponement is one of several this fall -- Holtec and Bamboo Insurance also pulled back -- suggesting the reopened IPO window investors expected has stalled broadly, not just for one company.→
- Sep 25, 2026The Fall 2026 IPO Window, By The Numbers2026's IPO market has priced 109 offerings raising $146.5 billion through mid-September, and this week's cohort -- a mix of pops, declines and a pulled listing -- shows the window staying open but increasingly selective.→
- Sep 25, 2026This Week's IPO Class Delivered A Split VerdictThe same week produced a 19% pop for Ligent, a 12% decline for Electra Therapeutics, and a pulled listing for Bamboo Insurance -- evidence the 2026 IPO window is open but pricing power now depends entirely on the individual deal.→
- Sep 24, 2026This Fall's IPO Cohort, Scored Deal By DealSix live IPO storylines this week produced wildly different outcomes -- from a 19% Hong Kong pop to a pulled US deal -- and the spread says this fall's IPO window rewards individual fundamentals, not just good timing.→
- Sep 24, 2026The Fall IPO Pipeline, By The NumbersSix companies are mid-IPO-process on US and Indian exchanges this week, from Oura's $15.6B roadshow to Bamboo Insurance's all-secondary listing, and the spread across sectors says the fall IPO window is genuinely open.→
- Sep 24, 2026Bamboo Insurance Pulls Its IPO Just Before PricingBamboo Insurance Services postponed its planned NYSE listing on the day it was set to price, citing financial-market volatility, after marketing an all-secondary offering targeting a roughly $3.24 billion valuation.→
- Sep 22, 2026Why Some Fall IPOs Are Filing While Others Are PricingThis fall's IPO pipeline is splitting between companies actually pricing and trading -- newcleo, Electra Therapeutics -- and a growing backlog of filed-but-not-priced names including Nscale and Wella, some sitting for weeks without terms.→
- Sep 21, 2026Electra Therapeutics Closes First Day Down 12%Electra Therapeutics priced its upsized IPO at $15 a share for roughly $350 million, then closed its first trading day on Nasdaq down nearly 12% at $13.25 -- a rockier debut than the biotech IPO market's recent run of first-day pops.→
- Sep 21, 2026Bamboo Insurance's IPO Won't Give The Company A DollarBamboo Insurance is marketing 35 million shares at $18-$20 for its NYSE debut under ticker BMB, but every share is being sold by backers CVC Capital Partners and White Mountains -- the company gets no proceeds.→
- Sep 14, 2026Why 2026 Has Fewer IPOs Than 2025 Despite Bigger OnesValue Add Pulse compared the 2026 US listing tally with 2025 and found slightly fewer deals despite record-sized offerings, a mix shift toward large asset-heavy issuers rather than a broad reopening.→
Coverage Timeline
newest firstAll Coverage
IPO
This Week's IPO Class Delivered A Split Verdict
The same week produced a 19% pop for Ligent, a 12% decline for Electra Therapeutics, and a pulled listing for Bamboo Insurance -- evidence the 2026 IPO window is open but pricing power now depends entirely on the individual deal.
DEEP DIVE
The Fall IPO Pipeline, By The Numbers
IPO
The Fall IPO Pipeline, By The Numbers
Six companies are mid-IPO-process on US and Indian exchanges this week, from Oura's $15.6B roadshow to Bamboo Insurance's all-secondary listing, and the spread across sectors says the fall IPO window is genuinely open.
BY THE NUMBERS
Bamboo Insurance's IPO Won't Give The Company A Dollar
IPOUp to $700M (secondary)
Bamboo Insurance's IPO Won't Give The Company A Dollar
Bamboo Insurance is marketing 35 million shares at $18-$20 for its NYSE debut under ticker BMB, but every share is being sold by backers CVC Capital Partners and White Mountains -- the company gets no proceeds.
DEEP DIVE
Three IPOs Set Terms In A $2.1B Week
IPO~$2.1B combined
Three IPOs Set Terms In A $2.1B Week
Holtec Nuclear, Bamboo Insurance and Electra Therapeutics set IPO terms within a day of each other, lining up roughly $1.8 billion of supply; with Orion180's $320 million deal, the week's calendar totals about $2.1 billion.
FOLLOW-UP
Value Add Research
Related Companies
Same sector
Sources & methodologyshow
Where these figures come from
- Bloombergmajor outlet2 facts
Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.